{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:34:15Z","timestamp":1783492455800,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.vaccine.2026.128256","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T12:41:46Z","timestamp":1769776906000},"page":"128256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pharmacy access and shingles vaccinations in the US: a propensity score matching analysis"],"prefix":"10.1016","volume":"75","author":[{"given":"Rachel","family":"Wittenauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth D.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Mooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Stergachis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128256_bb0005","author":"Immunization and Infectious Diseases"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128256_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7003a1","article-title":"Surveillance of Vaccination coverage among adult populations \u2014United States, 2018","volume":"70","author":"Lu","year":"2021","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.vaccine.2026.128256_bb0015","author":"US Centers for Disease Control and Prevention"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128256_bb0020","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1377\/hlthaff.2016.0462","article-title":"Modeling the economic burden of adult vaccine-preventable diseases in the United States","volume":"35","author":"Ozawa","year":"2016","journal-title":"Health Aff"},{"key":"10.1016\/j.vaccine.2026.128256_bb0025","article-title":"The economic value of Vaccination: why prevention is wealth","volume":"3","author":"Pasteur","year":"2015","journal-title":"J Mark Access Health Policy"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128256_bb0030","first-page":"137","article-title":"Pharmacists and immunization: increasing involvement over a century on JSTOR","volume":"41","author":"Grabenstein","year":"1999","journal-title":"Pharm Hist"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128256_bb0035","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1331\/154434506776180621","article-title":"Pharmacist involvement with immunizations: A decade of professional advancement","volume":"46","author":"Hogue","year":"2006","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.vaccine.2026.128256_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2020.12.024","article-title":"Strengthening pandemic preparedness through pharmacy and public health collaborations: findings from a facilitated discussion exercise","author":"Bacci","year":"2021","journal-title":"J Am Pharm Assoc"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128256_bb0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3390\/pharmacy8030140","article-title":"The role of hospital and community pharmacists in the management of COVID-19: towards an expanded definition of the roles, responsibilities, and duties of the pharmacist","volume":"8","author":"Bragazzi","year":"2020","journal-title":"Pharmacy"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128256_bb0050","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.japh.2022.08.010","article-title":"Essential services: quantifying the contributions of America\u2019s pharmacists in COVID-19 clinical interventions","volume":"62","author":"Grabenstein","year":"2022","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.vaccine.2026.128256_bb0055","author":"Influenza Vaccine Doses Distributed"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128256_bb0060","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.japh.2021.11.010","article-title":"Factors influencing series completion rates of recombinant herpes zoster vaccine in the United States: A retrospective pharmacy and medical claims analysis","volume":"62","author":"Patterson","year":"2022","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128256_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/21645515.2019.1637218","article-title":"The essential role of pharmacists facilitating vaccination in older adults: the case of herpes zoster","volume":"16","author":"Tak","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128256_bb0070","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.japh.2022.03.021","article-title":"Accessibility of adult immunizations in pharmacies compared to physician offices in low-income communities","volume":"62","author":"Popovian","year":"2022","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.vaccine.2026.128256_bb0075","article-title":"US centers for disease control and prevention. Adult immunization schedule by age. US CDC","year":"2024","journal-title":"Published"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128256_bb0080","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.vaccine.2023.12.042","article-title":"Comparison of adult hesitancy towards COVID-19 vaccines and vaccines in general in the USA","volume":"42","author":"Nguyen","year":"2024","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128256_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20043376","article-title":"Spillover of vaccine hesitancy into adult COVID-19 and influenza: the role of race, religion, and political affiliation in the United States","volume":"20","author":"Zhang","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.vaccine.2026.128256_bb0090","article-title":"Drugstore closures are leaving millions without easy access to a pharmacy","volume":"22","author":"Gregg","year":"2023","journal-title":"The Washington Post October"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128256_bb0095","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/1468-0009.12342","article-title":"Impact of pharmacists on access to vaccine providers: A geospatial analysis","volume":"96","author":"Shah","year":"2018","journal-title":"Milbank Quarterly"},{"key":"10.1016\/j.vaccine.2026.128256_bb0100","unstructured":"Berenbrok LA, Tang S, Coley KC, et al. Access to potential COVID-19 vaccine administration facilities: A geographic information systems analysis. p. 1\u201322. Published online 2021."},{"issue":"24","key":"10.1016\/j.vaccine.2026.128256_bb0105","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1016\/j.vaccine.2020.02.040","article-title":"Increasing adult vaccinations at a regional supermarket chain pharmacy: A multi-site demonstration project","volume":"38","author":"Coley","year":"2020","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128256_bb0110","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.vaccine.2020.01.061","article-title":"Pharmacists\u2019 impact on older adults\u2019 access to vaccines in the United States","volume":"38","author":"Newlon","year":"2020","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128256_bb0115","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.japh.2021.07.006","article-title":"Pharmacy deserts and patients with breast cancer receipt of influenza vaccines","volume":"61","author":"Neuner","year":"2021","journal-title":"J Am Pharm Assoc"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128256_bb0120","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.japh.2021.05.014","article-title":"Patient characteristics associated with the use of pharmacist-administered vaccination services and predictors of service utilization","volume":"61","author":"Rashrash","year":"2021","journal-title":"J Am Pharm Assoc"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128256_bb0125","first-page":"1958","article-title":"\u2018Pharmacy deserts\u2019 are prevalent in Chicago\u2019s predominantly minority communities","volume":"33","author":"Qato","year":"2014","journal-title":"Raising Medication Access Concerns Health Aff"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128256_bb0130","doi-asserted-by":"crossref","DOI":"10.1093\/haschl\/qxae035","article-title":"Locations and characteristics of pharmacy deserts in the United States: a geospatial study","volume":"2","author":"Wittenauer","year":"2024","journal-title":"Health Affairs Scholar"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128256_bb0135","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.vaccine.2018.12.003","article-title":"The effect of a prescription order requirement for pharmacist-administered vaccination on herpes zoster vaccination rates","volume":"37","author":"Tak","year":"2019","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128256_bb0140","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.amepre.2018.05.011","article-title":"Clinicians\u2019 and pharmacists\u2019 reported implementation of Vaccination practices for adults","volume":"55","author":"Lutz","year":"2018","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2026.128256_bb0145","author":"Shingles Vaccination"},{"key":"10.1016\/j.vaccine.2026.128256_bb0150","series-title":"Decennial Census","author":"Census Bureau","year":"2020"},{"key":"10.1016\/j.vaccine.2026.128256_bb0155","series-title":"2017-2021 5-year American community survey","author":"Census Bureau","year":"2026"},{"key":"10.1016\/j.vaccine.2026.128256_bb0160","article-title":"National and state-specific shingles Vaccination among adults aged \u226560 years","volume":"52(3):362","author":"Lu","year":"2017","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2026.128256_bb0165","article-title":"The role of social determinants in timely herpes zoster vaccination among older American adults","author":"Shuvo","year":"2021","journal-title":"Published online"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128256_bb0170","doi-asserted-by":"crossref","first-page":"555","DOI":"10.7326\/0003-4819-152-9-201005040-00005","article-title":"Barriers to the use of herpes zoster vaccine","volume":"152","author":"Hurley","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2026.128256_bb0175","series-title":"Prevention of Herpes Zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","first-page":"17","volume":"57(5)","author":"Harpaz","year":"2008"},{"key":"10.1016\/j.vaccine.2026.128256_bb0180","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jclinepi.2022.01.011","article-title":"Population median imputation was noninferior to complex approaches for imputing missing values in cardiovascular prediction models in clinical practice","volume":"145","author":"Berkelmans","year":"2022","journal-title":"J Clin Epidemiol"},{"issue":"20","key":"10.1016\/j.vaccine.2026.128256_bb0185","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/sim.3854","article-title":"The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies","volume":"29","author":"Austin","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2026.128256_bb0190","series-title":"The central role of the propensity score in observational studies for causal effects","volume":"70(1):41-55","author":"Rosenbaum","year":"2026"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128256_bb0195","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/rmdopen-2019-000953","article-title":"Viewpoint: three handy tips and a practical guide to improve your propensity score models","volume":"5","author":"Bergstra","year":"2019","journal-title":"RMD Open"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128256_bb0200","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/biomet\/asq035","article-title":"Bounded, efficient and doubly robust estimation with inverse weighting","volume":"97","author":"Tan","year":"2010","journal-title":"Biometrika"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128256_bb0205","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.leaqua.2010.10.010","article-title":"On making causal claims: A review and recommendations","volume":"21","author":"Antonakis","year":"2010","journal-title":"Leadersh Q"},{"key":"10.1016\/j.vaccine.2026.128256_bb0210","series-title":"R: A language and environment for statistical computing","author":"R Core Team","year":"2024"},{"issue":"37","key":"10.1016\/j.vaccine.2026.128256_bb0215","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1016\/j.vaccine.2023.07.025","article-title":"The potential impact of increased recombinant zoster vaccine coverage on the burden of herpes zoster among adults aged 50\u201359 years","volume":"41","author":"Singer","year":"2023","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128256_bb0220","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.2606","article-title":"Association between pharmacy closures and adherence to cardiovascular medications among older US adults","volume":"2","author":"Qato","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128256_bb0225","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/1475-6773.t01-1-00036","article-title":"Primary care, self-rated health, and reductions in social disparities in health","volume":"37","author":"Shi","year":"2002","journal-title":"Health Serv Res"},{"issue":"5","key":"10.1016\/j.vaccine.2026.128256_bb0230","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3122\/jabfm.16.5.412","article-title":"The relationship between primary care, income inequality, and mortality in US states, 1980\u20131995","volume":"16","author":"Shi","year":"2003","journal-title":"J Am Board Fam Pract"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128256_bb0235","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.amjmed.2007.10.021","article-title":"Health care utilization and the proportion of primary care physicians","volume":"121","author":"Kravet","year":"2008","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128256_bb0240","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1468-0009.2005.00409.x","article-title":"Contribution of primary care to health systems and health","volume":"83","author":"Starfield","year":"2005","journal-title":"Milbank Q"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128256_bb0245","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.28810","article-title":"State Telepharmacy policies and pharmacy deserts","volume":"6","author":"Urick","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.vaccine.2026.128256_bb0250","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1016\/j.sapharm.2022.07.045","article-title":"State-level policy efforts to regulate pharmacy benefit managers (PBMs)","volume":"18","author":"Mattingly","year":"2022","journal-title":"Research in Social and Administrative Pharmacy"},{"key":"10.1016\/j.vaccine.2026.128256_bb0255","author":"H.R.2759 - 117th Congress (2021\u2212-2022)"},{"issue":"6","key":"10.1016\/j.vaccine.2026.128256_bb0260","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.japh.2021.08.021","article-title":"Pharmacist provider status: geoprocessing analysis of pharmacy locations, medically underserved areas, populations, and health professional shortage areas","volume":"61","author":"Murphy","year":"2021","journal-title":"J Am Pharm Assoc"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128256_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2022.11.010","article-title":"Implementation of a herpes zoster immunization program in an outpatient hospital-based pharmacy","volume":"63","author":"Flaspohler","year":"2023","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128256_bb0270","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/jphsr\/rmaa022","article-title":"An adapted two-step floating catchment area method accounting for urban\u2013rural differences in spatial access to pharmacies","volume":"12","author":"Zhou","year":"2021","journal-title":"Journal of Pharmaceutical Health Services Research"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128256_bb0275","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.healthplace.2009.06.002","article-title":"An enhanced two-step floating catchment area (E2SFCA) method for measuring spatial accessibility to primary care physicians","volume":"15","author":"Luo","year":"2009","journal-title":"Health Place"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128256_bb0280","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/jamainternmed.2019.4588","article-title":"Assessment of pharmacy closures in the United States from 2009 through 2015","volume":"180","author":"Guadamuz","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128256_bb0285","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.vaccine.2023.12.040","article-title":"Utilization of immunization information systems (IIS) among independently owned community pharmacies: A national survey","volume":"42","author":"Meininger","year":"2024","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.vaccine.2026.128256_bb0290","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1016\/j.vaccine.2021.07.050","article-title":"Insurance reimbursements for recombinant zoster vaccine in the private sector","volume":"39","author":"Leidner","year":"2021","journal-title":"Vaccine"},{"issue":"50","key":"10.1016\/j.vaccine.2026.128256_bb0295","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1016\/j.vaccine.2022.10.065","article-title":"Recombinant zoster vaccine (RZV) second-dose series completion in adults aged 50\u201364 years in the United States","volume":"40","author":"Leung","year":"2022","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128256_bb0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-9276-12-18","article-title":"Patient-centred access to health care: Conceptualising access at the interface of health systems and populations","volume":"12","author":"Levesque","year":"2013","journal-title":"Int J Equity Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26000630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26000630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:48:00Z","timestamp":1772552880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26000630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":60,"alternative-id":["S0264410X26000630"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128256","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacy access and shingles vaccinations in the US: a propensity score matching analysis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128256"}}